Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study
Vito Lorusso(Ospedale Vito Fazzi), Mario De Lena(Radiation Oncology Institute), Grazia Nacci(University of Bari Aldo Moro), Bernardo Leone, V. Leonardi(University of Palermo), Annamaria Catino(Istituto Tumori Bari), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Giovanni Di Vagno(University of Bari Aldo Moro), G Gargano(Oncology Group of Southern Italy), Carlos Vallejo(Hospital General de Catalunya), M. Machiavelli, S. Palmeri(University of Palermo), Luigi Manzione, Giuseppe Loverro
Cited by 5
Related Papers
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|452
Randomized Trial Comparing Cisplatin, Gemcitabine, and Vinorelbine With Either Cisplatin and Gemcitabine or Cisplatin and Vinorelbine in Advanced Non–Small-Cell Lung Cancer: Interim Analysis of a Phase III Trial of the Southern Italy Cooperative Oncology Group
|Journal of Clinical Oncology|2000|177
Lapatinib in breast cancer
|Annals of Oncology|2007|129
Myocardial Atrophy and Chronic Mechanical Unloading of the Failing Human Heart
|Journal of the American College of Cardiology|2014|92